Skip to main content

Enhanced Recovery After Surgery (ERAS)

Enhanced Recovery After Surgery (ERAS) is a multimodal, multidisciplinary, evidence-based perioperative care pathway designed to minimize surgical stress, maintain physiologic homeostasis, and accelerate functional recovery while reducing complications, length of stay, and costs.[1] Originally developed by Henrik Kehlet's group in Copenhagen for colorectal surgery in the 1990s and formalized by the ERAS® Society (now active in more than 20 countries), ERAS has been extended to essentially every major surgical specialty — colorectal, gastric, hepatobiliary, pancreatic, thoracic, bariatric, orthopedic, gynecologic, head-and-neck, cardiac, and urologic — including the cornerstone urologic indication, radical cystectomy with urinary diversion.[1][2][3]

The practical rule for the reconstructive urologist: adherence drives outcomes. Patients in the highest-compliance quartile have roughly one-third the rate of moderate-to-severe complications of the lowest-compliance quartile across large prospective cohorts.[9][10] ERAS is not a collection of optional elements — it is a bundle that must be executed as a bundle.

See also: Analgesia, Nerve Blocks, Antithrombotic Therapy, Constipation, Frailty.

Core Principles — Two Fundamental Goals​

Every ERAS pathway, regardless of specialty, pursues two unifying aims:[1]

1. Minimize Surgical Stress and Optimize the Stress Response​

Surgery triggers catabolism, insulin resistance, and inflammation. Unchecked, these produce protein and muscle loss, cellular dysfunction, and prolonged recovery. ERAS counters with:

  • Reducing insulin resistance (carbohydrate loading, early nutrition, glucose control).
  • Epidural or regional analgesia to blunt the endocrine stress response.
  • Multimodal opioid-sparing analgesia (acetaminophen + NSAID baseline + regional adjuncts).
  • Early feeding and early mobilization to restore anabolic state.
  • Prehabilitation for high-risk patients.

2. Minimize Fluid Shifts​

Perioperative fluid excess is a major cause of ileus, pulmonary complications, and anastomotic edema — and it is historically rampant in long cystectomies and major reconstructions. ERAS targets euvolemia:[1]

  • Goal-directed fluid therapy using stroke-volume or pulse-pressure variation where available.
  • ≤30 mL/kg net IV fluid intake intraoperatively, with target weight gain kept under 2 kg.
  • IV fluids discontinued by ~24 hours postoperatively in an on-track patient.
  • Vasopressor-forward ("balanced") hemodynamic support instead of volume-forward.

The 21 Core ERAS Domains​

The ERAS® Society has codified roughly 21 perioperative domains that appear across specialty-specific guidelines, organized around the patient's timeline:[2]

Preoperative​

  • Preadmission information, education, and counseling
  • Preoperative optimization and prehabilitation
  • Avoidance of prolonged fasting; carbohydrate loading 2 hours before surgery
  • Minimal or no bowel preparation
  • Avoidance of sedative premedication

Intraoperative​

  • Standardized anesthetic protocols (often with epidural or spinal analgesia)
  • Minimally invasive approach when feasible
  • Prevention of hypothermia (forced-air warming; warmed fluids/insufflation gas)
  • Surgical site infection bundle (antimicrobial prophylaxis, skin preparation, timely redosing)
  • Avoidance or early removal of drains, NG tubes, and urinary catheters
  • Goal-directed fluid management with balanced crystalloids
  • Perioperative glucose control (target 140–180 mg/dL)

Postoperative​

  • Multimodal opioid-sparing analgesia
  • PONV prophylaxis (dual or triple, stratified by Apfel score)
  • Early oral nutrition — drinks and food on day of surgery
  • Prevention of postoperative ileus (peripherally-acting μ-opioid antagonists — e.g., alvimopan)
  • Early mobilization — out of bed on POD 0
  • VTE prophylaxis (LMWH; extended 4 weeks after pelvic oncology)

Program Management​

  • Dedicated ERAS coordinator (nurse or advanced practice provider)
  • Multidisciplinary team coordination (surgery, anesthesia, nursing, nutrition, PT, social work)
  • Audit and reporting of compliance and outcomes
  • Patient-reported outcomes monitoring

An ERAS program should implement at least 4 core domains before it can reasonably be called an ERAS strategy; the consistent evidence favors ≥70% compliance across all adopted elements.[2]

ERAS Surgical Safety Checklist​

A 2023 modified-Delphi consensus derived an ERAS Surgical Safety Checklist that integrates pathway elements into existing WHO-checklist timepoints — before anesthesia induction, before skin incision, and before the patient leaves the OR.[4] The checklist is designed to overlay, not replace, the standard surgical safety checklist and is the practical operational tool that converts guideline adoption into bedside compliance.

Clinical Outcomes​

Length of Stay​

ERAS reduces hospital LOS by 30–50% across specialties.[1] In meta-analysis of 42 RCTs, the mean difference is −2.35 days.[5][6]

Complications​

ERAS reduces total complications without increasing mortality or readmission across most specialties.[1][5][7][8] In colorectal surgery specifically, SSI rates (historically approaching 20%) and PONV rates (historically up to 80%) drop substantially under ERAS pathways.[7][8]

Bowel Function Recovery​

  • Time to first flatus: −0.82 days
  • Time to first defecation: −0.96 days[2][5]

Readmissions​

No increase overall; some evidence of reduced 30-day readmissions (RR 0.45).[2] One meta-analysis noted increased readmissions after upper-GI surgery (RR 1.92), suggesting particular caution in gastric cancer surgery.[5][6]

Cost​

Mean cost reduction ~$639 per episode without increased medical expenditure.[2][5][6]

Mortality​

No increase. Some populations — notably orthopedic surgery — show reduced 30-day mortality (OR 0.40).[6]

Dose-Response Relationship — POWER and POWER2​

The POWER study (colorectal surgery) and POWER2 (total hip/knee arthroplasty) prospectively demonstrated a dose-response relationship between ERAS compliance and outcomes:[9][10]

Outcome (highest vs lowest adherence quartile, colorectal)OR
Moderate-to-severe complications0.34
Overall complications0.33
Mortality0.27

Highest quartile in POWER used >77% of ERAS elements. Similar patterns were observed in POWER2 for hip and knee arthroplasty.

A 2024 JAMA Network Open systematic review of 142 studies confirmed LOS, readmission, complication, and mortality benefits but flagged substantial heterogeneity in which elements are implemented — only ~25% of studies report compliance, which is the single largest gap in the ERAS literature.[11]

ERAS in GU Reconstruction​

Radical Cystectomy — The Flagship Urologic ERAS Procedure​

The ERAS® Society's 2013 guideline for radical cystectomy was the first urology-specific pathway.[12] Subsequent work has consolidated the evidence base:

  • 2016 EAU Robotic Urology Section consensus on ERAS for robot-assisted radical cystectomy.[13]
  • 2020 BJUI Compass IPD meta-analysis — aggregate outcomes after ERAS implementation.[14]
  • 2024 EJSO update — evidence reaffirmed for contemporary MIS cystectomy cohorts.[15]

Cystectomy-specific elements beyond the generic pathway:

  • Alvimopan (12 mg PO preop, then BID until return of GI function; max 15 doses) — FDA-approved for accelerated bowel recovery after open radical cystectomy; reduces LOS by ~1 day in a multicenter RCT.[16]
  • No routine mechanical bowel preparation for bowel urinary diversion.[12][17]
  • Goal-directed fluid therapy — cystectomy is the canonical operation where historic overhydration drove ileus and neobladder edema.
  • Early NG-tube removal or no NGT at all.
  • Extended 4-week VTE prophylaxis for pelvic oncologic surgery.[18]
  • Dedicated stoma education and nursing pathway.

Aggregate benefit under a compliant cystectomy ERAS pathway:[13][14][15]

  • LOS reduced by 2–4 days
  • 30-day complication rate reduced by ~20–30%
  • No increase in readmission
  • No compromise of oncologic outcomes
  • Measurable cost reduction

Robotic Radical Prostatectomy (RARP)​

  • Increasingly performed as same-day discharge in ERAS programs. Reported same-day discharge rates exceed 90% in contemporary series, particularly the single-port transvesical approach.[3]
  • No routine pelvic drain.
  • Opioid-free or low-opioid discharge is now achievable — 96% of transvesical SP RP patients discharged without opioid prescription.

Partial and Radical Nephrectomy​

  • Same-day discharge is increasingly common for uncomplicated partial nephrectomy, especially with single-port low-anterior (LAA) and supine anterior retroperitoneal (SARA) approaches.
  • Minimize intraoperative fluids, particularly during clamped-parenchyma PN.
  • TAP or quadratus lumborum block for analgesia.

Major Reconstruction (Augmentation, Posterior Urethroplasty, Continent Diversion)​

No formal ERAS Society guideline specific to reconstructive urology yet, but the general principles apply — opioid-sparing analgesia, avoidance of MBP when bowel use is not the index operation, early mobilization and nutrition, and extended VTE prophylaxis for pelvic procedures.

Special Populations​

Elderly​

ERAS is safe and efficacious in elderly populations. Prehabilitation, frailty screening, and delirium-prevention bundles (acetaminophen baseline, regional over systemic opioids, early mobilization) are particularly high-yield.[7][8]

Pediatric​

Preliminary evidence suggests ERAS is safe and effective in pediatric surgical patients, though the literature is less robust than in adults.[19]

Implementation and Compliance​

Successful ERAS implementation requires:

  • Multidisciplinary team — surgeons, anesthesiologists, a dedicated ERAS coordinator, perioperative nurses, dietitians, physical therapists, and social work — working as a coordinated unit.[1][3]
  • Standardized written protocols tailored to specific procedures, incorporating ≥4 core ERAS domains at minimum.[2]
  • Continuous audit and monitoring of both protocol compliance and patient outcomes. Compliance — not protocol adoption per se — is what drives outcomes.[9][10][1]
  • Realistic compliance targets: published programs generally achieve ≥70% overall compliance, with early feeding and avoidance of peritoneal drainage historically the lowest-adherence elements.[2]

Expected Recovery Trajectory​

A patient progressing normally on an ERAS pathway should be drinking, eating, mobilizing, and sleeping on the day after surgery, with IV fluids discontinued by approximately 24 hours postoperatively.[1]

Practical Implementation Checklist​

For a reconstructive urology service launching or auditing an ERAS pathway:

  1. Dedicated ERAS coordinator — nurse, APP, or quality-improvement lead.
  2. Written procedure-specific protocol covering all pre-, intra-, and postoperative elements.
  3. Patient-facing pathway document given at the surgical consent visit and reviewed at the pre-admission call.
  4. Anesthesia alignment — agreed opioid-sparing induction, GDFT targets, and regional-block plan.
  5. Consensus ERAS surgical safety checklist integrated into WHO-checklist timepoints.[4]
  6. Prospective compliance audit — at minimum quarterly, with feedback to all disciplines.

References​

1. Ljungqvist O, Scott M, Fearon KC. "Enhanced Recovery After Surgery: A Review." JAMA Surg. 2017;152(3):292–298. doi:10.1001/jamasurg.2016.4952

2. Chau JPC, Liu X, Lo SHS, et al. "Perioperative Enhanced Recovery Programmes for Women With Gynaecological Cancers." Cochrane Database Syst Rev. 2022;3:CD008239. doi:10.1002/14651858.CD008239.pub5

3. Smith TW, Wang X, Singer MA, Godellas CV, Vaince FT. "Enhanced Recovery After Surgery: A Clinical Review of Implementation Across Multiple Surgical Subspecialties." Am J Surg. 2020;219(3):530–534. doi:10.1016/j.amjsurg.2019.11.009

4. Pilkington M, Nelson G, Cauley C, et al. "Development of an Enhanced Recovery After Surgery Surgical Safety Checklist Through a Modified Delphi Process." JAMA Netw Open. 2023;6(2):e2248460. doi:10.1001/jamanetworkopen.2022.48460

5. Lau CS, Chamberlain RS. "Enhanced Recovery After Surgery Programs Improve Patient Outcomes and Recovery: A Meta-Analysis." World J Surg. 2017;41(4):899–913. doi:10.1007/s00268-016-3807-4

6. Zhang X, Yang J, Chen X, et al. "Enhanced Recovery After Surgery on Multiple Clinical Outcomes: Umbrella Review of Systematic Reviews and Meta-Analyses." Medicine (Baltimore). 2020;99(29):e20983. doi:10.1097/MD.0000000000020983

7. Irani JL, Hedrick TL, Miller TE, et al. "Clinical Practice Guidelines for Enhanced Recovery After Colon and Rectal Surgery From the American Society of Colon and Rectal Surgeons and the Society of American Gastrointestinal and Endoscopic Surgeons." Surg Endosc. 2023;37(1):5–30. doi:10.1007/s00464-022-09758-x

8. Irani JL, Hedrick TL, Miller TE, et al. "Clinical Practice Guidelines for Enhanced Recovery After Colon and Rectal Surgery (ASCRS/SAGES)." Dis Colon Rectum. 2023;66(1):15–40. doi:10.1097/DCR.0000000000002650

9. Ripollés-Melchor J, Ramírez-Rodríguez JM, Casans-Francés R, et al. "Association Between Use of Enhanced Recovery After Surgery Protocol and Postoperative Complications in Colorectal Surgery: The POWER Study." JAMA Surg. 2019;154(8):725–736. doi:10.1001/jamasurg.2019.0995

10. Ripollés-Melchor J, Abad-Motos A, Díez-Remesal Y, et al. "Association Between Use of Enhanced Recovery After Surgery Protocol and Postoperative Complications in Total Hip and Knee Arthroplasty: The POWER2 Study." JAMA Surg. 2020;155(4):e196024. doi:10.1001/jamasurg.2019.6024

11. Sauro KM, Smith C, Ibadin S, et al. "Enhanced Recovery After Surgery Guidelines and Hospital Length of Stay, Readmission, Complications, and Mortality." JAMA Netw Open. 2024;7(6):e2417310. doi:10.1001/jamanetworkopen.2024.17310

12. Cerantola Y, Valerio M, Persson B, et al. "Guidelines for Perioperative Care After Radical Cystectomy for Bladder Cancer: Enhanced Recovery After Surgery (ERAS®) Society Recommendations." Clin Nutr. 2013;32(6):879–887. doi:10.1016/j.clnu.2013.09.014

13. Collins JW, Patel H, Adding C, et al. "Enhanced Recovery After Robot-Assisted Radical Cystectomy: EAU Robotic Urology Section Scientific Working Group Consensus View." Eur Urol. 2016;70(4):649–660. doi:10.1016/j.eururo.2016.05.020

14. Williams SB, Cumberbatch MGK, Kamat AM, et al. "Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-Analysis." BJUI Compass. 2020;1(1):5–15. doi:10.1002/bco2.9

15. Pang KH, Esperto F, Noon AP, et al. "Updated Evidence and Outcomes of Enhanced Recovery After Surgery Protocols in Radical Cystectomy." Eur J Surg Oncol. 2024;:S0748-7983(24)01611-1. doi:10.1016/j.ejso.2024.109541

16. Lee CT, Chang SS, Kamat AM, et al. "Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter, Randomized, Placebo-Controlled Trial." Eur Urol. 2014;66(2):265–272. doi:10.1016/j.eururo.2014.02.036

17. Large MC, Kiriluk KJ, DeCastro GJ, et al. "The Impact of Mechanical Bowel Preparation on Postoperative Complications for Patients Undergoing Cystectomy and Urinary Diversion." J Urol. 2012;188(5):1801–1805. doi:10.1016/j.juro.2012.07.039

18. Tikkinen KAO, Craigie S, Agarwal A, et al. "Procedure-Specific Risks of Thrombosis and Bleeding in Urological Non-Cancer Surgery: Systematic Review and Meta-Analysis." Eur Urol. 2018;73(2):236–241. doi:10.1016/j.eururo.2017.02.025

19. American College of Surgeons. Optimal Resources for Children's Surgical Care 2021. Barnhart D, Cartwright P, Derkay C, et al. American College of Surgeons; 2021.